Retroviridae

The Retroviridae is a very large family of complexly constructed, enveloped, RNA viruses with numerous animal-specific species (pathogenic to birds and mammals) as well as 2 major human pathogenic genera - Deltavirus and Lentivirus - with their species HTLV 1, HTLV 2 as well as HIV 1, HIV 2. The "Xenotropic murine leukemia virus-related virus", which belongs to the genus Gammaretrovirus, was first described in 2006 as a novel human pathogen in tissue samples from men with prostate cancer. Its pathogenic significance remains to be elucidated.

Retroviridae virions are spherical enveloped viral particles with a size of 80-100 nm in diameter. The glycoprotein surface projections are about 8 nm long. The inner core is formed by the viral nucleocapsid. The apparently spherical nucleocapsid (nucleoid) is eccentric in members of the genus Betaretrovirus, concentric in members of the genera Alpharetrovirus, Gammaretrovirus, Deltaretrovirus, and Spumavirus, and rod- or frustoconical in members of the genus Lentivirus. The virions of the Retroviridae are sensitive to heat, detergents, and formaldehyde. The surface glycoproteins can be partially removed by proteolytic enzymes. The virions are relatively resistant to UV light.

The currently valid taxonomy by the International Committee on Taxonomy of Viruses (ICTV) shows the family of Retroviridae (Retroviruses) in the order Orthovirales with 2 subfamilies and 11 genera:

Subfamily: Orthoretroviruses (Orthoretrovirinae)

Genera:

• Alpharetrovirus
• Betaretrovirus (with species Human mammary tumor virus)
• Gammaretrovirus
• Deltaretrovirus (with species Primate T-lymphotropic virus 1 (HTLV-1), Primate T-lymphotropic virus 2 (HTLV-2))
• Epsilon retrovirus
• Lentivirus (with species HIV-1, HIV-2, SIV, BIV, FIV)
• Subfamily: Foamy- or Spumaretroviruses (Spumaretrovirinae)

5 species of retroviruses are known to be human pathogens:

In the genus Deltavirus:

• Human T-lymphotropic virus 1 (HTLV-1)
• Human T-lymphotropic virus 2 (HTLV-2)

In the genus Lentivirus:

• Human immunodeficiency virus-1 (HIV-1)
• Human immunodeficiency virus type II (HIV-2)

In the genus Gammaretrovirus

• Xenotropic murine leukemia virus-related virus (XMRV)

Structure of the virus:

The viral genome, characteristic of members of the subfamily Orthoretrovirinae, consists of a dimer of linear, positive-sense ssRNA, each monomer being 7-13 kb in size. The RNA constitutes about 2% of the dry weight of the virion. The monomers are held together by hydrogen bonds. Each RNA monomer is polyadenylated at the 3′-end and has a cap structure at the 5′-end and is associated with a specific tRNA molecule base-paired to a region (called the primer-binding site) near the 5′-end of the RNA, comprising about 18 nt at the 3′-end of the tRNA.

Proteins: Proteins make up about 60% of the dry weight of the virion. IN the envelope is found the glycoprotein env (gp160 - note: env stands for envelope), which is important for adsorption. This is composed of the superimposed SU protein (gp 120/surface - binding to the cellular CD4 receptor) and the TM protein (gp 41/transmembrane - fusogenic capacity). Both proteins are encoded by the viral env gene (envelope gene). Some members of the subfamily Spumaretrovirinae have a third env protein. Furthermore, there are 3-6 internal non-glycosylated structural proteins (encoded by the gag gene).

M (matrix protein): The M protein (p17) is often acylated with a myristyl residue covalently linked to the amino-terminal glycine. It is netted beneath the envelope. The envelope encloses the capsid, which in lentiviruses is conically formed by the capsid protein CA(p24). Also present in the capsid are 3 enzymes important for replication and maturation: reverse transcriptase/RNAse (TR/NASE -p66/51-), integrase (INT . p35-), protease (PROT - p9-). Other proteins present in the virion are accessory protein or capsid interacting protein p16. The complex retroviruses of the genera Deltaretrovirus, Epsilonretrovirus, Lentivirus and Spumavirus also encode non-structural proteins. Many of these viruses further encode transcriptional transactivators required for LTR promoter expression or proteins required for RNA export from the nucleus.

Lipids: Lipids make up about 35% of the dry weight of the virion. They are derived from the plasma membrane of the host cell.

Carbohydrates: Virions consist of about 3% by weight of carbohydrates. This value varies depending on the virus. Usually both envelope proteins (gp120/gp41) are glycosylated.

Genome organization and replication: The viruses of the members of the subfamily Orthoretrovirinae carry two copies of the RNA genome (gRNA). They form nucleocapsids with the protein NC (p7). Infectious viruses have four major genes encoding virion proteins in the order: 5′-gag-pro-pol-env-3′. Some retroviruses contain genes encoding nonstructural proteins that are important for regulating gene expression and viral replication. Others carry cell-derived sequences important for pathogenesis. In many cases, cell-derived sequences form a fused gene with a viral structural gene, which is then translated into a chimeric protein (e.g., Gag-Onc protein).

Replication:

Entry into the host cell is mediated by the interaction between the virion SU glycoprotein (gp160) and specific receptors on the host cell surface. Numerous "entry receptors" have been identified. For human immunodeficiency virus (HIV), both CD4 (an immunoglobulin-like molecule with a single transmembrane region) and the chemokine receptors CCR5 and CXCR4, respectively, are required for membrane fusion. The interaction of ligand and receptor results in fusion of the viral envelope with the plasma membrane. The capsid is released into the cytoplasm.

The viral genome, although of positive polarity, does not serve for direct translation at ribosomes. Rather, it serves as a template for the reverse transcriptase (RT) contained in the capsid. The RT makes a double-stranded copy of DNA from the RNA. In its final form, the linear dsDNA derived from the viral ssRNA genome contains long terminal repeats (LTRs) consisting of unique sequences from the 3′ (U3) and 5′ (U5) ends of the viral RNA flanking a repeated sequence (R) located near both ends of the RNA. The process of reverse transcription is characterized by a high frequency of recombination that results from the transfer of RT from one template RNA to another. The mechanism of reverse transcription allows high recombination rates and genetic diversity for many of the retroviruses. The synthesized DNA copy is then transported through the nuclear pore into the nucleus in the form of the so-called "preintegration complex". The integrase contained in the pre-integration complex ensures the integration of the viral DNA into the genome of the host. This state is called a provirus. In this form, the virus can persist latently in a resting cell for a very long time. Upon host cell activation, cellular RNA polymerase begins transcription of the proviral DNA. The resulting mRNAs encode accessory proteins (Hof H et al. 2019).

After translation, the nucleocapsids assemble with capsule proteins, enzymes and other accessory proteins. Capsid formation occurs due to viral protease activity. The capsids are assembled at the plasma membrane (in the majority of genera) in human pathogenic species and released from the cell by a process of budding. Budding appears to occur preferentially at specialized membrane microdomains called lipid rafts. Polyprotein processing of internal proteins occurs simultaneously with or immediately after maturation of virions. During retrovirus maturation, cleavage of the structural precursor Gag polyprotein by the viral protease induces architectural restructuring of the viral particle from an immature to a mature, infectious form (Pornillos O et al. 2019).

Antigenic properties: Virion proteins contain type-specific and group-specific determinants. Some type-specific determinants of envelope glycoproteins are involved in antibody-mediated virus neutralization. Group-specific determinants are shared by members of a serogroup and may also be shared between members of different serogroups within a given genus. There is evidence of weak cross-reactivity between members of different genera. Epitopes that elicit T cell responses are found on many structural proteins. Antigenic properties are not used in the classification of members of the family Retroviridae.

Biological properties:

Retroviruses are widely distributed as exogenous infectious agents of vertebrates. Endogenous proviruses, which arose at some point by infection of germline cells, are inherited according to Mendelian rules. They are widespread in vertebrates and may account for up to 10% of genomic DNA. The vast majority have suffered inactivating mutations and cannot produce infectious virus. A few can exert significant biological effects after activation, either by replication in a manner indistinguishable from exogenous viruses or after recombination with replication-competent viruses.

Retroviruses are associated with a variety of diseases. These include: malignancies, including certain leukemias, lymphomas, sarcomas, and other tumors of mesodermal origin; breast carcinomas and carcinomas of the liver, lung, and kidney; immunodeficiencies (such as AIDS); autoimmune diseases; lower motor neuron diseases; and various acute diseases involving tissue damage. Some retroviruses appear to be nonpathogenic. Retroviruses are transmitted horizontally via a number of routes, including blood, saliva, sexual contact, etc., and via direct infection of the developing embryo or via milk or perinatal routes. Endogenous retroviruses are transmitted vertically by inheritance of proviruses.

The human pathogenic retroviruses are so closely related to those of other primates that the two groups are often grouped together under the name primate retroviruses. It is assumed that the human retroviruses arose by transmission of simian retroviruses to humans. For HTLV 1(Human T-cell leukemia virus 1/2) and HTLV 2, this transmission probably occurred thousands of years ago. For HIV 1 (human immunodeficiency virus 1/ 2) and HIV 2, it probably did not occur until the 20th century.

1. Coffin JM et al (2016) The discovery of reverse transcriptase. Annu Rev Virol 29:29-51.
2. Doolittle RF et al (1989) Origins and evolutionary relationships of retroviruses. Quart Rev Biol 64: 1-30.
3. Freed EO et al (2007) HIVs and their replication. In: Knipe DM Howley PM (Eds.) Fields Virology 5th edn. Lippincott Williams and Wilkins, Philadelphia pp 2107-2185.
4. Hof H et al (2019): Special virology. In: Hof H, Schlüter D, Dörries R, eds Duale Reihe Medizinische Mikrobiologie. 7th, completely revised and expanded edition. Stuttgart: Thieme p 219-225
5. Leis J et al (1988) Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 62: 1808-1809.
6. Pornillos O et al (2019) Maturation of retroviruses. Curr Opin Virol 36:47-55.
7. Varmus H (1988) Retroviruses. Science 240:1427-1435.